Exacerbation rate, health status and mortality in COPD – a review of potential interventions

References

• BonetTSepultrechretum sive anatomica pructica ex Cadaveribus Morbo denatis, proponens Histoa’s Observations omnium pene humani corporis affectuum, ipsarcomoue Causas recordatis revelansGeneva1679
   Google Scholar
• PettyTLThe history of COPDInt J Chron Obstruct Pulmon Dis2006131418046898
   PubMedGoogle Scholar
• LaennecRTHA treatise on the diseases of the chest (English translsation for the French). Preface and notes by Forbes JLondon T and G Underwood1837
   Google Scholar
• TiffeneauRPinelliAFAire circulant et air captif dans l’exploration de la function ventilatrice pulmonaiteParis Med194713362462818909782
   PubMedGoogle Scholar
• FletcherCMJonesNLBurrowsBNidenAHAmerican emphysema and British bronchitis: A standardized comparative studyAm Rev Resp Dis19649011314178623
   PubMed Web of Science ®Google Scholar
• BurrowsBFletcherCMHeardBEThe emphysematous and bronchial types of chronic airway obstruction: a clinopathological study of patients in London and ChicagoLancet196618308354159957
   PubMed Web of Science ®Google Scholar
• JonesNLBurrowsBFletcherCMSerial studies of 100 patients with chronic airway obstruction in London and ChicagoThorax1967223273356035796
   PubMed Web of Science ®Google Scholar
• BriscoeWANashESThe slow space in chronic obstructive pulmonary diseasesAnn N Y Acad Sci196512170672214309579
   PubMed Web of Science ®Google Scholar
• SukumalchantraYWilliamsMHSerial studies of pulmonary function in patients with chronic obstructive pulmonary diseaseAm J Med1965399419455853045
   PubMed Web of Science ®Google Scholar
• HoggJCMacklemPTThurlbeckWMSite and nature of airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med1968278135513605650164
   PubMed Web of Science ®Google Scholar
• CosioMGhezzoHHoggJCThe relations between structural changes in small airwayys and pulmonaryfunction testsN Engl J Med197829812771281651978
   PubMed Web of Science ®Google Scholar
• PettyTLSilversGWStanfordRESmall airway disease is associated with elastic recoil changes in excised human lungsAm Rev Respir Dis198413042456742609
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD)Am J Respir Crit Care Med1995152S77S1207582322
   PubMed Web of Science ®Google Scholar
• ERS Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)Eur Respir J19958139814207489808
   PubMed Web of Science ®Google Scholar
• BTSGuidelinesFor the management of chronic obstructive pulmonary diseaseBMJ199752S2S15
   Google Scholar
• ManninoDMDohertyDESonia BuistAGlobal Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) studyRespir Med2006100111512215893923
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBMJ1977116451648871704
   PubMed Web of Science ®Google Scholar
• AnthonisenNRWrightECHodgkinJEPrognosis in chronic obstructive pulmonary diseaseAm Rev Respir Dis198613314203510578
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA19941615391541
   Google Scholar
• AnthonisenNRSmoking, lung function, and mortalityThorax20005572973410950888
   PubMed Web of Science ®Google Scholar
• HoleDJWattGCMDaveySmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women:findings from the Renfew and Paisley prospective population studyBMJ19963137117158819439
   PubMed Web of Science ®Google Scholar
• ThomasonMJStrachanDPWhich spirometric indices best predict death from chronic obstructive pulmonary diseaseThorax20005578578810950899
   PubMed Web of Science ®Google Scholar
• AïtKhaledNEnarsonDAOttmaniSEl SonyAEltiganiMSepulvedaRChronic airflow limitation in developing countries: burden and prioritiesInt J Chron Obstruct Pulmon Dis2007214115018044686
   PubMedGoogle Scholar
• BuistASMcBurnieMAVollmerWMBOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet200737074175017765523
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 19902020: Global Burden of Disease StudyLancet1997349149815049167458
   PubMed Web of Science ®Google Scholar
• SeemungalTHarrinarineRRiosMObstructive Lung Disease in Acute Medical PatientsWest Indian Med J2008577174
   Web of Science ®Google Scholar
• LiuSZhouYWangXBiomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South ChinaThorax2007628389
   Web of Science ®Google Scholar
• DriscollTNelsonDISteenlandKThe global burden of non-malignant respiratory disease due to occupational airborne exposuresAm J Ind Med20054843244516299701
   PubMed Web of Science ®Google Scholar
• TakahashiTIchinoseMInoueHShiratoKHattoriTTakishimaTUnderdiagnosis and undertreatment of COPD in primary care settingsRespirology2003850450814629656
   PubMed Web of Science ®Google Scholar
• JindalSKAggarwalANGuptaDA review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smokingIndian J Chest Dis Allied Sci20014313914711529432
   PubMedGoogle Scholar
• GroenewaldPVosTNormanR2000S Afr Med J20077(8 Pt 2)674681
   Google Scholar
• ChanYeungMAïtKhaledNWhiteNIpMSTanWCThe burden and impact of COPD in Asia and AfricaInt J Tuberc Lung Dis200482124
   Web of Science ®Google Scholar
• FeenstraTLvan GenugtenMLHoogenveenRTWoutersEFRuttenvan MölkenMPThe impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the NetherlandsAm J Respir Crit Care Med200116459059611520721
   PubMed Web of Science ®Google Scholar
• ManninoDMHomaDMAkinbamiLJFordESReddSCChronic Obstructive Pulmonary Disease Surveillance – United States, 19712000MMWR200251S6116
   Google Scholar
• VarkeyABChronic obstructive pulmonary disease in women: exploring gender differencesCurr Opin Pulm Med2004109810315021178
   PubMed Web of Science ®Google Scholar
• HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and metaanalysisEur Respir J20062852353216611654
   PubMed Web of Science ®Google Scholar
• SorianoJBMaierWEggerPRecent trends in physician diagnosed COPD in women and men in the UKThorax20005578979410950900
   PubMed Web of Science ®Google Scholar
• SchirnhoferLLamprechtBVollmerWMCOPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) studyChest2007131293617218553
   PubMed Web of Science ®Google Scholar
• HanMKPostmaDManninoDM2007Gender and chronic obstructive pulmonary disease: why it mattersAm J Respir Crit Care Med2007176121179118417673696
   PubMed Web of Science ®Google Scholar
• ManninoDMBuistoASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
   PubMed Web of Science ®Google Scholar
• TagerISpeizerFERole of infection in chronic bronchitisN Engl J Med197529211563571802896
   PubMed Web of Science ®Google Scholar
• JefferyPKStructural and inflammatory changes in COPD: a comparison with AsthmaThorax1998531291369624299
   PubMed Web of Science ®Google Scholar
• MontoASHigginsMWRossHWThe Tecumseh study of respiratory illness. Acute infection in chronic respiratory disease and comparison groupsAm Rev Infect Dis1975112736
   Google Scholar
• KannerRERenzettiADJrKlauberMRSmithCBGoldenCAVariables associated with changes in spirometry in patients with obstructive lung diseasesAm J Med1979674450313706
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHeshfordEWHardingGKMNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med19871061962043492164
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001611608161810806163
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
   PubMed Web of Science ®Google Scholar
• JohnstonAKManninoDMEpidemiology of COPD exacerbationsWedzichaJAMartinezFExacerbations Of Chronic Obstructive Pulmonary Disease (COPD)New YorkInforma Healthcare2008
   Google Scholar
• BurgePSCalverleyPMAJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ20003201297130310807619
   PubMed Web of Science ®Google Scholar
• SeemungalTStockleyRCalverleyPHaganGWedzichaJAInvestigating New Standards for Prophylaxis In Reduction of Exacerbations The INSPIRE Study MethodologyCOPD2007417718317729060
   PubMedGoogle Scholar
• WilkinsonTMADonaldsonGCHurstJRSeemungalTARWedzichaJAEarly therapy improves outcomes of exacerbations of Chronic Obstructive Pulmonary DiseaseAm J Respir Crit Care Med20041691298130314990395
   PubMed Web of Science ®Google Scholar
• LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med200817739640118048806
   PubMed Web of Science ®Google Scholar
• VijaysarathaKStockleyRAReported and unreported exacerbations of COPD: analysis by diary cardsChest2008133344117989153
   PubMed Web of Science ®Google Scholar
• McCormickAFlemingDCharltonJMorbidity statistics from general practice: Fourth national study 19912: Office of Population Census and LondonSurveys; 1995
   Google Scholar
• NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med19993401941194710379017
   PubMed Web of Science ®Google Scholar
• GoldacreMJFergusonJAInpatient workload in medical specialities: demographic studies and time trends from linked statisticsQ J Med199588649660
   Google Scholar
• VestboJSorensenTLangePBrixATorrePViskumKLongterm effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease:a randomised controlled trialLancet19993531819182310359405
   PubMed Web of Science ®Google Scholar
• ForemanMGDeMeoDLHershCPReillyJJSilvermanEKClinical determinants of exacerbations in severe, earlyonset COPDEur Respir J20073061124113017715170
   PubMed Web of Science ®Google Scholar
• PatelISSeemungalTARWilksMLloyd OwenSDonaldsonGCWedzichaJARelationship between bacterial colonisation and the frequency, character and severity of COPD exacerbationsThorax20025775976412200518
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax20005511412010639527
   PubMed Web of Science ®Google Scholar
• SeemungalTARHarperOwenRBhowmikARespiratory viruses and symptoms, inflammatory markers in acute exacerbations of COPDAm J Respir Crit Care Med20011618162311719299
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMABurgePSJonesPWon behalf of the Isolde Study GroupHealth status deterioration in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116312212811208636
   PubMed Web of Science ®Google Scholar
• KannerREAnthonisenNRConnettJfor the Lung Health StudyLower respiratory illnesses promote FEV1 decline in smokers but not exsmokers with mild chronic obstructive pulmonary disease: results from the Lung Health StudyAm J Respir Crit Care Med200116435836411500333
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669
   PubMed Web of Science ®Google Scholar
• SolerCatalunaJJMartínezGarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax20056092593116055622
   PubMed Web of Science ®Google Scholar
• JaradNAWedzichaJABurgePSCalverleyPMAn observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study GroupRespir Med19999316116610464871
   PubMed Web of Science ®Google Scholar
• SuissaSErnstPVandemheenKLAaronSDMethodological issues in therapeutic trials of COPDEur Respir J20083192793318216056
   PubMed Web of Science ®Google Scholar
• KeeneONCalverleyPMAJonesPWVestboJAndersonJAStatistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisitedEur Respir J200832172418591336
   PubMed Web of Science ®Google Scholar
• SuissaSExacerbations and intent-to-treat analyses in randomised trialsEur Respir J2008321117111818827158
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMThe St. Georges Respiratory QuestionnaireRespir Med199185Suppl B25311759018
   PubMed Web of Science ®Google Scholar
• JonesPWHealth status measurement in chronic obstructive pulmonary diseaseThorax20015688088711641515
   PubMed Web of Science ®Google Scholar
• OkubadejoAAJonesPWWedzichaJAQuality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemiaThorax19965144478658368
   PubMed Web of Science ®Google Scholar
• SchrierADekkerFWKapteinAADijkmanJHQuality of life in elderly patients with chronic nonspecific lung disease seen in family practiceChest1990988948992209145
   PubMed Web of Science ®Google Scholar
• JonesPWBoshTKQuality of life changes in COPD patients with SalmeterolAm J Respir Crit Care Med1997155128312899105068
   PubMed Web of Science ®Google Scholar
• BorsonSMcDonaldGJGayleTDeffebachMLakshminarayanSVanTuinenCImprovement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary diseasePsychosomatics1992331902011557484
   PubMed Web of Science ®Google Scholar
• Intermittent Positive Pressure Breathing Trial Group (IPPB Trial Group). Intermittent positive pressure breathing of COPDAnn Intern Med1983996126206357018
   PubMed Web of Science ®Google Scholar
• MeechamJonesDJPaulEAJonesPWWedzichaJANasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnoeic COPDAm J Respir Crit Care Med19951525385447633704
   PubMed Web of Science ®Google Scholar
• GarrodRMikelsonsCPaulEAWedzichaJARandomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2000162(4 Pt 1)133541
   Web of Science ®Google Scholar
• WijkstraPJAltenaRVKraanJOttenVPostmeDSKoeterGHQuality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at homeEur Resp J19947269273
   PubMed Web of Science ®Google Scholar
• GoldsteinRSGortEDHStubbingDAvendanoMAGuyattGHRandomised controlled trial of respiratory rehabilitationLancet1994344139413977968075
   PubMed Web of Science ®Google Scholar
• WedzichaJABestallJCGarrodRGarnhamRPaulEAJonesPWRandomised controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scaleEur Respir J1998123633699727786
   PubMed Web of Science ®Google Scholar
• OsmanLMGoddenDJFriendJARLeggeJSDouglasJGQuality of life and hospital readmission in patients with chronic obstructive pulmonary diseaseThorax19975267719039248
   PubMed Web of Science ®Google Scholar
• SpencerSJonesPWfor the GLOBE Study GroupTime course of recovery of health status following an infective exacerbation of chronic bronchitisThorax20035858959312832673
   PubMed Web of Science ®Google Scholar
• GuyattGHBermanLBTowensendMPugsleySOChambersLWA measure of quality of life for clinical trials in chronic lung diseaseThorax1987427737783321537
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure for chronic airflow limitation the St. George’s Respiratory QuestionnaireAm Rev Respir Dis1992145132113271595997
   PubMed Web of Science ®Google Scholar
• WilliamsJESinghSJSewellLGuyattGHMorganMDDevelopment of a self-reported Chronic Respiratory Questionnaire (CRQSR)Thorax2001561295495911713359
   PubMed Web of Science ®Google Scholar
• JaeschkeRSingerJGuyattGHMeasurement of health status. Ascertaining the minimal clinically important differenceControl Clin Trials19891044074152691207
   PubMedGoogle Scholar
• JonesPWLassersonDRelationship between change in the St. Georges Respiratory Questionnaire score and the patient’s perception of treatment efficacy after one years therapy with nedocromil sodiumAm J Respir Crit Care Med1994149A211
   Google Scholar
• JonesPLInterpreting thresholds for a clinically significant change in health status in asthma and COPDEur Respir J20021939840411936514
   PubMed Web of Science ®Google Scholar
• BroekhuizenRWoutersEFCreutzbergECScholsAMRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax200661172216055618
   PubMed Web of Science ®Google Scholar
• GarrodRMarshallJBarleyEFredericksSHaganGThe relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)Prim Care Respir J20071623624017665081
   PubMedGoogle Scholar
• SeemungalTARCho Fook LunJDavisGPlasma homocysteine is elevated in COPD patients and is related to COPD severityInt J Chron Obstruct Pulmon Dis20072331332118229569
   PubMedGoogle Scholar
• LopezADMathersCDEzzatiMJamisonDTMurrayCJGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet2006367174757
   Web of Science ®Google Scholar
• OliveiraAFValenteJGLeiteICThe disease burden attributable to smoking in the state of Rio de Janeiro, Brazil in 2000Clinics20086321522218438576
   PubMed Web of Science ®Google Scholar
• SahaRNathASharmaNBadhanSKIngleGKChanging profile of disease contributing to mortality in a resettlement colony of DelhiNatl Med J India20072012512717867616
   PubMed Web of Science ®Google Scholar
• The Office of National Statistics of the United Kingdom Available at: www.statistics.gov.uk/
   Google Scholar
• The National Health Executive of the United Kingdom Available at: www.nationalhealthexecutive.com
   Google Scholar
• ManninoDMBramanSThe epidemiology and economics of chronic obstructive pulmonary diseaseProc Am Thorac Soc2007450252617878461
   PubMedGoogle Scholar
• FosterTSMillerJDMartonJPCaloyerasJPRussellMWMenzinJAssessment of the Economic Burden of COPD in the USA Review and Synthesis of the LiteratureCOPD2006321121817361502
   PubMedGoogle Scholar
• NurmagambetovTAtherlyAWilliamsSHolguinFManninoDMReddSCWhat is the cost to employers of direct medical care for chronic obstructive pulmonary diseaseCOPD200632039
   Google Scholar
• TraverGAMeasures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways diseaseHeart Lung1998176896973192415
   PubMed Web of Science ®Google Scholar
• HurdSThe impact of COPD on lung health worldwide: epidemiology and incidenceChest20001171S5S10673465
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• PostmaDSPetersISteenhuisEJSluiterHJModerately severe chronic airflow obstruction. Can corticosteroids slow down obstructionEur Respir J1988122263366234
   PubMed Web of Science ®Google Scholar
• DompelingEvan SchayckCPvan GrunsvenPMvan HerwaardenCLAkkermansRMolemaJSlowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4 year prospective studyAnn Intern Med19931187707788470851
   PubMed Web of Science ®Google Scholar
• CallahanCMDittusRSKatzBPOral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A metaanalysisAnn Intern Med19911142162231824614
   PubMed Web of Science ®Google Scholar
• Jan GrunsvenPMvan SchayckCPDerenneJPKerstjensHARenkemaTEPostmaDSLong term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a metaanalysisThorax19995471410343624
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLASchoutenJPPostmaDSPrideNBLongterm treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smokingN Engl J Med19993401948195310379018
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMABurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J2004231518431851
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJTRial of Inhaled STeroids ANd longacting beta2 agonists study groupCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet200336144945612583942
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J200321748751
   Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J20032291291914680078
   PubMed Web of Science ®Google Scholar
• Global Initiative for Obstructive Lung Disease Update Available from http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=989.2007
   Google Scholar
• BoydGMoriceAHPounsfordJCSiebertMPeslisNCrawfordCAn evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)Eur Respir J1997108158219150318
   PubMed Web of Science ®Google Scholar
• MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest199911595796510208192
   PubMed Web of Science ®Google Scholar
• DahlRGreefhorstLANowakDFormoterol in Chronic Obstructive Pulmonary Disease I Study GroupInhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116477878411549532
   PubMed Web of Science ®Google Scholar
• RennardSIAndersonWZuWallackRUse of a longacting inhaled beta2adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011631087109211316640
   PubMed Web of Science ®Google Scholar
• SalpeterSRBuckleyNSSalpeterEEMetaanalysis: anticholinergics, but not βagonists, reduce severe exacerbations and respiratory mortality in COPDJ Gen Intern Med2006211011101916970553
   PubMed Web of Science ®Google Scholar
• GudmundssonGGislasonTLindbergEMortality in COPD patients discharged from hospital: the role of treatment and comorbidityRespir Res2006710916914029
   PubMed Web of Science ®Google Scholar
• SiafakasNMVermeirePPrideNBOptimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEur Respir J19958139814207489808
   PubMed Web of Science ®Google Scholar
• GrossNJSkorodinMSRole of the parasympathetic system in airway obstruction due to emphysemaN Engl J Med19843114214256749189
   PubMed Web of Science ®Google Scholar
• GrossNJCoESkorodinMSCholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjectsChest1989969847
   Web of Science ®Google Scholar
• IncorvaiaCRiarioSforzaGGPravettoniCYacoubMRFratiFImpairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropiumInt J Chron Obstruct Pulmon Dis2008312312618488435
   PubMedGoogle Scholar
• SinghDTiotropium more knowledge leads to more questionsInt J Chron Obstruct Pulmon Dis20083iii
   Google Scholar
• KawayamaTHoshinoTIchikiMKurume COPD Study Group Effect of addon therapy of tiotropium in COPD treated with theophyllineInt J Chron Obstruct Pulmon Dis2008313714718488437
   PubMedGoogle Scholar
• KestenSCassaburiRKukafkaDCooperCBImprovement in selfreported exercise participation with the combination of tiotropium and rehabilitative training in COPD patientsInt J Chron Obstruct Pulmon Dis2008312713618488436
   PubMedGoogle Scholar
• JohanssonGLindbergARombergKNordströmLGerkenFRoquetABronchodilator efficacy of tiotropium in patients with mild to moderate COPDPrim Care Respir J20081716917518536860
   PubMedGoogle Scholar
• AndòFRuggeriPGirbinoGCazzolaMTiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPDRespir Med200810281581818343646
   PubMed Web of Science ®Google Scholar
• HaagSMatthiesenSJuergensURRackéKMuscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblastsEur Respir J20083255556218480105
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWWannerASanPGZuWallackRLA longterm evaluation of oncedaily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPDutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J20021920921611871363
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once daily inhaled anticholinergic bronchodilatorAnn Intern Med200514331732616144890
   PubMed Web of Science ®Google Scholar
• DonohueJFvan NoordJABatemanEDA 6 month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest2002122475512114338
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBTashkinDPClinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trialCOPD2004130331217136995
   PubMedGoogle Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4 year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLFergussonDCanadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasonesalmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med200714654555517310045
   PubMed Web of Science ®Google Scholar
• SinghDBrooksJHaganGCahnAO’ConnorBJSuperiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPDThorax20086359259818245142
   PubMed Web of Science ®Google Scholar
• RabeKFTimmerWSagkriotisAVielKComparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPDChest200813425526218403672
   PubMed Web of Science ®Google Scholar
• NajafzadehMMarraCASadatsafaviMCostEffectiveness of Therapy with Combinations of LongActing Bronchodilators and Inhaled Steroids for Treatment of COPDThorax20086396296718621985
   PubMed Web of Science ®Google Scholar
• KudohSAzumaAYamamotoMIzumiTAndoMImprovement of survival in patients with diffuse panbronchiolitis treated with low dose erythromycinAm J Respir Cri Care Med199815718291832
   PubMed Web of Science ®Google Scholar
• TakedaHMiuraHKawahiraMLongterm administration study on TE031 (A56268) in the treatment of diffuse panbronchiolitisKansenshogaku Zasshi19896371782526188
   PubMedGoogle Scholar
• YamamotoMKondoATamuraMIzumiTInaYNodaMLongterm therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitisNihon Kyobu Shikkan Gakkai Zasshi199028130513132273658
   PubMedGoogle Scholar
• WolterJSeeneySBellSEffect of long term treatment with azithromycin on disease parameters in cystic fibrosis:a randomized trialThorax2002572126
   Web of Science ®Google Scholar
• EquiABalfourLynnIMBushARosenthalMLong term azithromycin in children with cystic fibrosis:a randomised, placebocontrolled crossover trialLancet200236097898412383667
   PubMed Web of Science ®Google Scholar
• SaimanLMarshallBCMayerHamblettNMacrolide Study GroupAzithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trialJAMA20032901749175614519709
   PubMed Web of Science ®Google Scholar
• ClementATamaletALerouxERavillySFaurouxBJaisJPLong term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled TrialThorax20066189590216809416
   PubMed Web of Science ®Google Scholar
• SuzukiTYanaiMYamayaMErythromycin and Common Cold in COPDChest 1202001730733
   Google Scholar
• SeemungalTWilkinsonTMAHurstJRPereraWSapsfordRJWedzichaJALong term macrolide therapy is associated with decreased COPD exacerbation frequencyAm J Respir Crit Care Med20081781139114718723437
   PubMed Web of Science ®Google Scholar
• RossiAKristufekPLevineBEFormoterol in Chronic Obstructive Pulmonary Disease (FICOPD) II Study GroupComparison of the efficacy, tolerability and safety of formoterol dry powder and oral slow-release theophylline in treatment of COPDChest20021211058106911948033
   PubMed Web of Science ®Google Scholar
• ZhouYWangXZengXPositive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 yearRespirology20061160361016916334
   PubMed Web of Science ®Google Scholar
• RennardSISchachterNStrekMRickardKAmitOCilomilast for COPD: results of a 6 month, placebocontrolled study of a potent, selective inhibitor of phosphodiesterase 4Chest2006129566616424413
   PubMed Web of Science ®Google Scholar
• Fan ChungKPhosphodiesterase inhibitors in airways diseaseEur J Pharmacol200653311011716458289
   PubMed Web of Science ®Google Scholar
• NicholKLBakenLNelsonARelation between influenza vaccination and out patient visits, hospitalisation and mortality in elderly patients with chronic lung diseaseAnn Intern Med199913039740310068413
   PubMed Web of Science ®Google Scholar
• GrangerRWaltersJPoolePJInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseCochrane Database Syst Rev20064CD00139017054135
   PubMed Web of Science ®Google Scholar
• AlfagemeIVazquezRReyesNClinical efficacy of antipneumococcal vaccination in patients with COPDThorax20066118919516227328
   PubMed Web of Science ®Google Scholar
• ColletJPDucruetTHaiderSEffect of an immunostimulating agent on acute exacerbations and hospitalization in COPD patientsAm J Respir Crit Care Med1997156171917249412546
   PubMed Web of Science ®Google Scholar
• SprenkleMDNiewoehnerDEMacDonaldRRutksIWiltTJClinical efficacy of OM85 BV in COPD and chronic bronchitis:a systematic reviewCOPD2005216717517136978
   PubMedGoogle Scholar
• PoolePJBlackPNOral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic reviewBMJ2001322127174 [Updated at Cochrane Database Syst Rev 2006 Jul 19;3:CD001287]
   Google Scholar
• DecramerMRuttenvan MölkenMDekhuijzenPNEffects of Nacetyl cysteine on outcomes in COPD (BRONCHUS trial)Lancet2005365155260
   Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebocontrolled studyLancet20083712013201818555912
   PubMed Web of Science ®Google Scholar
• GriffithsTLBurrMLCampbellIAResults at 1 year of outpatient multidisciplinary pulmonary rehabilitationLancet20003553626810665556
   PubMed Web of Science ®Google Scholar
• BoxallAMBarclayLSayersACaplanGAManaging chronic obstructive pulmonary disease in the community. A randomized controlled trial of homebased pulmonary rehabilitation for elderly housebound patientsJ Cardiopulm Rehabil20052537838516327534
   PubMedGoogle Scholar
• FoglioKBianchiLAmbrosinoNIs it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2 year controlled studyChest20011191696170411399693
   PubMed Web of Science ®Google Scholar
• RingbaekTJBrøndumEBoltonSMartinezGLangeP[Rehabilitation of patients with chronic obstructive pulmonary disease. Effect of a 7 week programme after 12 months]Ugeskr Laeger20071691572157617484828
   PubMedGoogle Scholar
• PuhanMAScharplatzMTroostersTSteurerJRespiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality a systematic reviewRespir Res200565415943867
   PubMed Web of Science ®Google Scholar
• FoglioKBianchiLBrulettiGSeven year time course of lung function, symptoms, healthrelated quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programsRespir Med20071011961197017531455
   PubMed Web of Science ®Google Scholar
• Di MeoFPedoneCLubichSPizzoliCTraballesiMIncalziRAAge does not hamper the response to pulmonary rehabilitation of COPD patientsAge Ageing20083753053518565981
   PubMed Web of Science ®Google Scholar
• GarciaAymerichJFarreroEFélezMAIzquierdoJMarradesRMAntóJMfor the Estudi del Factors de Risc d’Agudització de la MPOC investigatorsRisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax20035810010512554887
   PubMed Web of Science ®Google Scholar
• GarciaAymerichJLangePBenetMSchnohrPAntóJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax20066177277816738033
   PubMed Web of Science ®Google Scholar
• LightowlerJVWedzichaJAElliottMWRamFSNoninvasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease:Cochrane systematic review and metaanalysisBMJ200332618512543832
   PubMed Web of Science ®Google Scholar
• TuggeyJMPlantPKElliottMWDomiciliary noninvasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysisThorax20035886787114514940
   PubMed Web of Science ®Google Scholar
• CliniESturaniCRossiAThe Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patientsEur Respir J20022052953812358325
   PubMed Web of Science ®Google Scholar
• BudweiserSHitzlAPJörresRAImpact of noninvasive home ventilation on longterm survival in chronic hypercapnic COPD: a prospective observational studyInt J Clin Pract2007611516152217686094
   PubMed Web of Science ®Google Scholar
• XiangPCZhangXYangJNThe efficacy and safety of long term home noninvasive positive pressure ventilation in patients with stable severe chronic obstructive pulmonary diseaseZhonghua Jie He He Hu Xi Za Zhi20073074675018218204
   PubMedGoogle Scholar
• WedzichaJAOutcome of longterm noninvasive positivepressure ventilationRespir Care Clin N Am2002855957312602415
   PubMedGoogle Scholar
• Nocturnal Oxygen Therapy Trial Group (NOTT)Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease:a clinical trialAnn Intern Med1980933913986776858
   PubMed Web of Science ®Google Scholar
• 178Medical Research Council Working Party (MRC)Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working PartyLancet198116816866162061
   PubMed Web of Science ®Google Scholar
• KimVBendittJOWiseRASharafkhanehAOxygen therapy in chronic obstructive pulmonary diseaseProc Am Thorac Soc2008551351818453364
   PubMedGoogle Scholar
• ChaouatAWeitzenblumEKesslerRA randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patientsEur Respir J1999141002100810596681
   PubMed Web of Science ®Google Scholar
• TanniSEValeSALopesPSGuiotokoMMGodoyIGodoyIInfluence of the oxygen delivery system on the quality of life of patients with chronic hypoxemiaJ Bras Pneumol20073316116717724535
   PubMedGoogle Scholar
• Breekveldt-PostmaNSKoerselmanJErkensJALammersJWHeringsRMEnhanced persistence with tiotropium compared with other respiratory drugs in COPDRespir Med20071011398140517368011
   PubMed Web of Science ®Google Scholar
• BlaisLBourbeauJSheehyOLeLorierJInhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatmentCan Respir J200411273215010729
   PubMedGoogle Scholar
• FergusonGTFunckBrentanoCFischerTDarkenPReisnerCCardiovascular safety of salmeterol in COPDChest20031231817182412796155
   PubMed Web of Science ®Google Scholar
• RodrigoGJNanniniLJRodríguezRoisinRSafety of longacting betaagonists in stable COPD: a systematic reviewChest2008133107987
   Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCARamFSTiotropium for stable chronic obstructive pulmonary disease: A meta-analysisThorax200661854862 Erratum in: Thorax. 2006;62:19116844726
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKFurbergCDInhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and metaanalysisJAMA20083001439145018812535
   PubMed Web of Science ®Google Scholar
• AlsaeediASinDDMcAlisterFAThe effects of inhaled corticosteroids in chronic obstructive pulmonary disease:a systematic review of randomized placebocontrolled trialsAm J Med2002113596512106623
   PubMed Web of Science ®Google Scholar
• GarbeESuissaSLeLorierAssociation of inhaled corticosteroid use with cataract extraction in elderly patentsJAMA19982805395439707144
   PubMed Web of Science ®Google Scholar
• CummingRGMitchellPLeederSRUse of inhaled corticosteroids and the risk of cataractsN Engl J Med19973378149203425
   PubMed Web of Science ®Google Scholar
• WongCAWalshLJSmithCJInhaled corticosteroid use and bonemineral density in patients with asthmaLancet20003551399140310791523
   PubMed Web of Science ®Google Scholar
• LipworthBJSystemic adverse effects of inhaled corticosteroid therapy: A systematic review and metaanalysisArch Intern Med199915994195510326936
   PubMed Web of Science ®Google Scholar
• GoldkornADiottoPBurgessCThe pulmonary and extrapulmonary effects of highdose formoterol in COPD: a comparison with salbutamolRespirology2004910210814982610
   PubMed Web of Science ®Google Scholar
• RosenkranzBRouzierRKruseMSafety and tolerability of highdose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary diseaseRespir Med200610066667216303295
   PubMed Web of Science ®Google Scholar
• CampbellSCCrinerGJLevineBECardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary diseasePulm Pharmacol Ther20072057157916911869
   PubMed Web of Science ®Google Scholar
• ShethKWassermanRLLincourtWRLocantoreNWCarranzaRosenzweigJCrimCFluticasone propionate/salmeterol hydrofluoroalkane via metereddose inhaler with integrated dose counter: Performance and patient satisfactionInt J Clin Pract2006601218122416981966
   PubMed Web of Science ®Google Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med200810259360418083019
   PubMed Web of Science ®Google Scholar
• JanssensWVandenBrandePHardemanEInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J200831788317898020
   PubMed Web of Science ®Google Scholar
• JarvisSIndPWShinerRJInhaled therapy in elderly COPD patients; time for reevaluation?Age Ageing20073622138
   Web of Science ®Google Scholar
• AlShowairRATarsinWYAssiKHPearsonSBChrystynHCan all patients with COPD use the correct inhalation flow with all inhalers and does training helpRespir Med20071012395240117629471
   PubMed Web of Science ®Google Scholar
• BartaSKCrawfordARobertsCMSurvey of patients’ views of domiciliary nebuliser treatment for chronic lung diseaseRespir Med20029637538112117035
   PubMed Web of Science ®Google Scholar
• SeemungalTARWedzichaJAIntegrated care: a new model for COPD management?Eur Respir J20062813
   Web of Science ®Google Scholar
• van CampenCSixmaHJKerssensJJPetersLAssessing noninstitutionalized asthma and COPD patients’ priorities and perceptions of quality of health careJ Asthma1997345315389428299
   PubMed Web of Science ®Google Scholar
• SixmaHJvan CampenCKerssensJJPetersLQuality of care from the perspective of elderly people: the QUOTEelderly instrumentAge Ageing200029173810690690
   PubMed Web of Science ®Google Scholar
• BourbeauJJulienMMaltaisFChronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. 2003. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific selfmanagement interventionArch Intern Med200316358559112622605
   PubMed Web of Science ®Google Scholar
• SridharMTaylorRDawsonSRobertsNJPartridgeMRA nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary diseaseThorax20086319420017901162
   PubMed Web of Science ®Google Scholar
• TaylorSJCandyBBryarRM2005Effectiveness of nursing and nurse led chronic disease management innovations for patients with chronic obstructive pulmonary disease: systematic review of evidenceBMJ200533148516093253
   PubMed Web of Science ®Google Scholar
• CasasATroostersTGarciaAymerichJmembers of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patientsEur Respir J20062812313016611656
   PubMed Web of Science ®Google Scholar
• GarciaAymerichJHernandezCAlonsoAEffects of an integrated care intervention on risk factors of COPD readmissionRespir Med20071011462146917339106
   PubMed Web of Science ®Google Scholar
• MonninkhofEvan der ValkPSchermerTvan der PalenJvan HerwaardenCZielhuisGEconomic evaluation of a comprehensive selfmanagement programme in patients with moderate to severe chronic obstructive diseaseChron Respir Dis2004171616281663
   PubMedGoogle Scholar
• SteutenLVrijhoefBVan MerodeFWesselingGJSpreeuwenbergCEvaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary diseaseInt J Qual Health Care20061842943617032687
   PubMed Web of Science ®Google Scholar
• LacasseYGoldsteinRLassersonTJMartinSPulmonary rehabilitation for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20064CD00379317054186
   PubMed Web of Science ®Google Scholar